Olivier van Not

8PUBLICATIONS
30CO-AUTHORS
Epidemiological modellingOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 22, 2025
Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma.

Saskia de Groot, Hedwig M Blommestein, Brenda Leeneman

|Aug 10, 2024
Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients.

Daan Jan Willem Rauwerdink, Olivier van Not, Melissa de Meza

|Jun 26, 2024
Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide study.

Manja Bloem, Olivier J van Not, Maureen J B Aarts

|Feb 27, 2023
Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trials.

Melissa M de Meza, Willeke A M Blokx, Han J Bonenkamp

|Jan 21, 2023
Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome Analysis.

Melissa M De Meza, Willeke A M Blokx, Johannes J Bonenkamp

Pageof 2